Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue ...

Harnessing the body's B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern ...

Researchers at the University of Geneva developed CAR-T cells targeting the glioblastoma marker PTPRZ1, showing efficacy ...

Researchers have developed a promising CAR-T cell therapy targeting glioblastoma, the most aggressive brain tumor.

Researchers have discovered that the antidepressant vortioxetine effectively combats glioblastoma, a deadly brain tumor, in ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

From a recent study by Mayo Clinic, discover how preoperative radiotherapy could improve survival rates for glioblastoma ...

Glioblastoma, an aggressive brain cancer, has a very poor prognosis.  More than 95% of glioblastoma patients die within five ...

By Dr. Priyom Bose, Ph.D. Researchers find that the antidepressant vortioxetine may offer new hope for glioblastoma patients ...

Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival after diagnosis of less ...

Glioblastoma is a particularly aggressive brain tumour that at present is incurable. Cancer doctors can extend patients' life ...

Glioblastoma is the most common and aggressive brain tumor, with patients surviving less than two years after diagnosis.